IL33 and retinopathy of prematurity: In an observational study on infants born less than 32 weeks’ gestation with a birth weight less than 1500 g, IL-33 was evaluated in cord blood and serum from ROP infants pre- and post-laser treatment and compared to gestation- and weight-matched controls.